Effects of cuminaldehyde on melanoma cells

Phytotherapy Research

Volumn 22, Issue 6, 2008, Pages 809-813

  Nitoda, Teruhiko ^a   Fan, Maria D ^a   Kubo, Isao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B16 F10 melanoma cell; Cuminaldehyde; Melanin formation

Indexed keywords

2,4 DIMETHOXYBENZALDEHYDE; ANISALDEHYDE; ARBUTIN; BENZALDEHYDE DERIVATIVE; CUMINALDEHYDE; MELANIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; MEDICINAL PLANT; MELANOMA B16; MELANOMA CELL; NONHUMAN;

ANIMALS; BENZALDEHYDES; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MELANINS; MELANOMA; MICE; MOLECULAR STRUCTURE;

MURINAE;

EID: 46849113677     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2374     Document Type: Article

References (15)

1. Briganti S, Camera E, Picardo M. 2003. Chemical and instrumental approachs to treat hyperpigmentation. Pigment Cell Res 16: 101-110.
2. Ha TJ, Tamura S, Kubo I. 2005. Effects of mushroom tyrosinase on anisaldehyde. J Agric Food Chem 53: 7024-7028.
3. Kageyama A, Oka M, Okada T et al. 2004. Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase. J Biol Chem 279: 27774-27780.
4. Kubo I, Kinst-Hori I. 1998. Tyrosinase inhibitors from cumin. J Agric Food Chem 46: 5338-5341.
5. Lee HS. 2002. Tyrosinase inhibitors of Pulsatilla cernua root-derived materials. J Agric Food Chem 50: 1400-1403.
6. Maeda K, Fukuda M. 1996. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharm Exp Ther 276: 765-769.
7. Mayer AM, Harel E, Ben-Shaul R. 1966. Assay of catechol oxidase: a critical comparison of methods. Phytochemistry 5: 783-789.
8. Nagata H, Takekoshi S, Takeyama R, Homma T. 2004. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res 17: 66-73.
9. Nihei K, Kubo I. 2003. Identification of oxidation product of arbutin in mushroom tyrosinase assay system. Bioorg Med Chem Lett 13: 2409-2412.
10. Patlewicz G, Basketter DA, Smith CK, Hotchkiss AM, Roberts D. 2001. Skin-sensitization structure-activity relationships for aldehydes. Contact Dermatitis 44: 331-336.
11. Prezioso JA, Epperly MW, Wang N, Bloomer WD. 1992. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4- S-cysteaminylphenol in melanoma cells. Cancer Lett 63: 73-79.
12. Sánchez-Ferrer A, Rodríguez-López JN, Garcia-Canovas F, García-Carmona F. 1995. Tyrosinase: A comprehensive review of its mechanism. Biochem Biophys Acta 1247: 1-11.
13. Schulz GE. 1996. Porins: general to specific, native to engineered passive pores. Curr Opin Struct Biol 6: 485-490.
14. Venkatasamy R, Faas L, Young AR, Raman A, Hider RC. 2004. Effects of piperine analogues on stimulation of melanocyte proliferation and melanocyte differentiation. Bioorg Med Chem 12: 1905-1920.
15. Xu Y, Stokes AH, Freeman WM, Kumer SC, Vogt BA, Vrana KE. 1997. Tyrosinase mRNA is expressed in human substantia nigra. Mol Brain Res 45: 159-162.